Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Taxus capsule maintenance study in non-small cell lung cancer
ChiCTR-OPC-17012318Phase 4Not yet recruiting
- Sponsor
- Guang'anmen Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of compound yew capsule, pemetrexed and gemcitabine in non-small cell lung cancer (NSCLC) (4 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Progression-free survival. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
compound yew capsulepemetrexedgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-OPC-17012318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17012318.